Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Only a fraction of patients with cancer respond to immune checkpoint blockade (ICB) treatment, but current decision-making procedures have limited accuracy. In this study, we developed a machine learning model to predict ICB response by integrating genomic, molecular, demographic and clinical data f...

Ausführliche Beschreibung